Investing

Vertex Pharmaceuticals : VRTX

VRTX

Stock Data

$460.37

$3.49 (0.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vertex Pharmaceuticals Inc is a pioneering biotechnology firm focused on creating innovative treatments for cystic fibrosis (CF) and other serious diseases. It offers a range of CF therapies, including TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, targeting different age groups and genetic mutations. Beyond CF, Vertex is exploring treatments for pain, sickle cell disease, beta thalassemia, and Type 1 Diabetes through advanced clinical trials. Founded in 1989 and based in Boston, Massachusetts, Vertex collaborates with leading biotech entities to expand its therapeutic portfolio, aiming to address unmet medical needs.

All Vertex Pharmaceuticals Articles

248 Articles

Lee Jackson | Oct 29, 2025 at 8:35 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: United Health, SoFi, Skyworks, Energy Transfer and More

Pre-Market Futures: The futures are trading higher this morning after another stellar day across Wall Street on Tuesday, as all…

Rich Duprey | Jun 15, 2025 at 6:34 AM EDT

Can a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million?

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require…

Rich Duprey | Jun 15, 2025 at 5:45 AM EDT

3 Monster Stocks to Confidently Own for the Next 10 Years

Buy-and-hold investing is a time-tested strategy that rewards patience and discipline. By owning high-quality stocks for at least three to…

Rich Duprey | Apr 24, 2025 at 1:14 PM EDT

Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a…

Trey Thoelcke | Feb 16, 2025 at 8:45 AM EST

A Buffett Buy, a Biotech IPO, and Other Big Insider Buying

The most notable insider purchases of the past week came from return buyers, including Warren Buffett. Another biotech IPO also…

Rich Duprey | Oct 31, 2024 at 9:30 AM EDT

Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied…

Chris MacDonald | Sep 23, 2024 at 8:52 AM EDT

The 3 Top Pharma Stocks to Buy in September 2024

Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized…

Rich Duprey | Sep 8, 2024 at 12:32 PM EDT

2 Biotech Bets to Buy in September

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or…

Rich Duprey | Sep 6, 2024 at 9:54 AM EDT

Buy These 3 Small-Cap Stocks for 90% to 301% Returns

There has been a noticeable shift in the stock market over the last two months. Investors are moving away from…

Rich Duprey | Aug 27, 2024 at 12:15 PM EDT

Goldman Sachs Predicts a Double-Digit Rally for These 2 Growth Stocks

The tech stock selloff in July surprised the market but not those investors who were paying attention. As far back…

Joshua Rodriguez | Jul 17, 2024 at 9:22 AM EDT

Add These 5 Hot Biotech Stocks In July

Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in…

Lee Jackson | May 31, 2023 at 8:54 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro,…

Lee Jackson | May 5, 2023 at 8:53 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: CVS Health, McDonald’s, Newell Brands, PacWest, ZoomInfo and More

Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and…

Lee Jackson | Jan 18, 2023 at 8:52 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: BP, Exxon Mobil, Kroger, Microsoft, RingCentral, Wayfair, Wendy’s and More

Wednesday's top analyst upgrades and downgrades included BP, ConocoPhillips, Equity Residential, Exxon Mobil, Global Payments, Kroger, Microsoft, NRG Energy, RingCentral,…

Lee Jackson | Dec 20, 2022 at 8:46 AM EST

Tuesday’s Top Analyst Downgrades and Upgrades: AT&T, Baxter, Lennar, L3 Harris, MGM Resorts, Nvidia and More

Tuesday's top analyst upgrades and downgrades included AT&T, Baxter International, Centene, Darden Restaurants, Lennar, L3 Harris Technologies, MGM Resorts International,…